Drugs / FMT capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07533227 | May 2026 → May 2027 expected | hypoproteinemia, hypercatabolic | Hua Jiang | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07533227 ↗ |
| Route | Oral | “Fecal microbiota capsules will be orally administered at three time points: Day 0, Day 28, and Day 56.” NCT07533227 ↗ |